Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant
1 clinical trials · Condition
◉ Watch Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer (NCT03912818) | Stanford University | 2019-04-10 |
Track Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant automatically
Every clearance here is in the API, with alerts when new ones post.